In the last trading session, 1.78 million shares of the Scilex Holding Company (NASDAQ:SCLX) were traded, and its beta was 1.07. Most recently the company’s share price was $0.37, and it changed around $0.0 or 0.63% from the last close, which brings the market valuation of the company to $89.71M. SCLX currently trades at a discount to its 52-week high of $2.63, offering almost -610.81% off that amount. The share price’s 52-week low was $0.35, which indicates that the current value has risen by an impressive 5.41% since then. We note from Scilex Holding Company’s average daily trading volume that its 10-day average is 1.44 million shares, with the 3-month average coming to 1.75 million.
Scilex Holding Company stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SCLX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Scilex Holding Company (NASDAQ:SCLX) trade information
Instantly SCLX has showed a green trend with a performance of 0.63% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4232 on recent trading dayincreased the stock’s daily price by 12.57%. The company’s shares are currently down -13.53% year-to-date, but still down -10.49% over the last five days. On the other hand, Scilex Holding Company (NASDAQ:SCLX) is -23.24% down in the 30-day period. We can see from the shorts that 4.91 million shares have been sold at a short interest cover period of 3.25 day(s).
Scilex Holding Company earnings are expected to increase by 53.91% in 2025, but the outlook is positive 27.89% per year for the next five years.
SCLX Dividends
Scilex Holding Company’s next quarterly earnings report is expected to be released in March.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 24.22% of Scilex Holding Company shares, and 14.47% of them are in the hands of institutional investors. The stock currently has a share float of 19.09%.
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 5.94 shares worth $2.19 million, making up 2.44% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.71 shares worth around $1.37 million, which represents about 1.53% of the total shares outstanding.
